Ophthalmology · Woodland Park, NJ
NPI
1841222502
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1225 McBride Ave Ste 204
Woodland Park, NJ, 07424
Phone (973) 785-2050
Groups this clinician bills Medicare through
Medicare paid, 2024
$498K
6,833 services
Medicare patients, 2024
1,087
Average age 76
Drug cost, 2024
$5.4M
10,848 prescriptions
Company payments, 2025
$448K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jai G Parekh was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,265 times for 757 patients. In total Jai G Parekh billed 6,833 services in 43 codes, and Medicare paid $498K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,265 | 757 | $12.96 | $16K |
| 99213 Office E&M - Established | Office | 900 | 605 | $71.80 | $65K |
| 92250 Angiography | Office | 758 | 736 | $28.23 | $21K |
| 92012 Ophthalmological E&M | Office | 439 | 358 | $54.24 | $24K |
| 83861 Clinical Chemistry | Office | 434 | 218 | $22.03 | $9,561 |
| 92083 Vision, Hearing, and Speech Services | Office | 409 | 352 | $50.30 | $21K |
| 92014 Ophthalmological E&M | Office | 364 | 344 | $84.94 | $31K |
| 99214 Office E&M - Established | Office | 343 | 338 | $99.75 | $34K |
| 68761 Eye | Office | 331 | 219 | $145.56 | $48K |
| 92133 Computerized Ophthalmic Imaging | Office | 313 | 308 | $27.64 | $8,653 |
| 92020 Ophthalmological E&M | Office | 250 | 242 | $22.25 | $5,563 |
| 66821 Cataract Surgery | Office | 151 | 99 | $274.71 | $41K |
| 92004 Ophthalmological E&M | Office | 105 | 105 | $94.67 | $9,940 |
| 76519 Ultrasound - Nonspecific | Office | 90 | 86 | $56.92 | $5,123 |
| 68841 Eye | Facility | 81 | 50 | $13.90 | $1,126 |
By year: 2022 $490K for 5,171 services; 2023 $508K for 5,224 services; 2024 $498K for 6,833 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 434 | 218 | $22.03 | $9,561 |
Medicare prescription drug claims, 2024
In 2024, the drug Jai G Parekh prescribed most often to Medicare patients was Latanoprost, with 1,628 prescriptions and refills. In total Jai G Parekh wrote 10,848 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,628 | 3,049 | 397 | $18K |
| Restasis Cyclosporine | 1,240 | 2,240 | 373 | $1.3M |
| Lumigan Bimatoprost | 1,201 | 1,998 | 271 | $518K |
| Cyclosporine Generic | 968 | 1,864 | 281 | $573K |
| Xiidra Lifitegrast | 963 | 1,775 | 401 | $1.2M |
| Prednisolone Acetate Generic | 397 | 435 | 173 | $12K |
| Combigan Brimonidine Tartrate/Timolol | 374 | 558 | 80 | $119K |
| Ketorolac Tromethamine Generic | 364 | 402 | 165 | $6,600 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 307 | 541 | 71 | $4,538 |
| Cequa Cyclosporine | 287 | 455 | 86 | $251K |
| Ciprofloxacin Hcl Generic | 276 | 296 | 136 | $2,973 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 223 | 410 | 59 | $41K |
| Moxifloxacin Moxifloxacin Hcl | 205 | 205 | 92 | $4,153 |
| Vyzulta Latanoprostene Bunod | 199 | 312 | 50 | $94K |
| Rhopressa Netarsudil Mesylate | 174 | 254 | 34 | $79K |
Brand drugs: 7,586 claims; generic drugs: 3,262 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jai G Parekh $448K ($448K in general payments such as food, travel and fees) from 22 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $148K.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 100 | $148K |
| Bausch & Lomb Americas Inc. BLCO | 140 | $116K |
| Glaukos Corporation GKOS | 33 | $50K |
| Sight Sciences, Inc. SGHT | 41 | $47K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 57 | $37K |
| Abbvie Inc. ABBV | 45 | $18K |
| Dompe US, Inc. | 36 | $12K |
| New World Medical,Inc. | 14 | $9,714 |
| Amgen Inc. AMGN | 12 | $3,534 |
| Carl Zeiss Meditec, Inc. | 3 | $2,246 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.